Studies suggest ADAMTS13 deficiency may also play a role in the long-term complications of COVID-19 or “Long COVID”, which is estimated to affect 30–40% of individuals after infection with SARS-CoV-2. This evidence concerns the gene ADAMTS13 and infection.